Skip to content

Author

L. Yurttaş

We have 3 of 156 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Design, synthesis, in vitro and in silico anticancer activity evaluation of novel thiosemicarbazide/butanoic acid hybrids

3e was found to have selective cytotoxic activity against cancer cells, which didn’t cause significant damage to non-cancerous cells, and may be effective on cancer patients without showing any side effects.

Aybüke Züleyha Kaya, Derya Osmani̇ye, A. Evren et al. · 0 citations
Open access Aug 2026

Investigation of the In Vitro and In Silico Anticancer Potential of Novel 4‐Arylthiazole‐Hydrazone Derivatives

The novel 4‐aryl‐2‐hydrazinothiazole derivatives synthesized and evaluated for their anticancer activity in MCF‐7 breast cancer, A549 lung cancer, and L929 normal cell lines were found to exhibit high cytotoxicity, particularly showing more selective and high‐potential antiproliferative activity on the MCF‐7 cell line.

Zeynep Zişan Demirci, Erol Akgün, G. Çiftçi et al. · 0 citations
Open access Aug 2026

Evaluation of Anticancer and Anti‐Inflammatory Activities of some Thiazole Derivatives

2‐thiazoline, a derivative containing 2‐thiazoline, which showed the most potential in terms of both anticancer and anti‐inflammatory activity among all compounds, was subjected to molecular docking studies on Caspase‐3 and COX‐1 enzymes and found to interact with the hydrophobic regions of amino acids.

Dilek Erdaş, A. Evren, Gülşen Akali̇n Çi̇ftçi̇ et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.